Biohaven Pharmaceutical Holding - 48 Year Dividend History | BHVN

Historical dividend payout and yield for Biohaven Pharmaceutical Holding (BHVN) since 1971. The current TTM dividend payout for Biohaven Pharmaceutical Holding (BHVN) as of June 14, 2019 is $0.00. The current dividend yield for Biohaven Pharmaceutical Holding as of June 14, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.796B $0.000B
Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company's pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.398B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83